As of Dec 15
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 23.75, with a high estimate of 23.75 and a low estimate of 23.75. The median estimate represents a +466.83% increase from the last price of 4.19.
The current consensus among 1 polled investment analysts is to Sell stock in Pain Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.